(F) L3.1 Non-malignnt WBC disorders Flashcards

1
Q

causes of non-malignant WBC disorders

A

genetic or acquired

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

causes: Infection, trauma, injury, or inflammatory
responses.
● Types of Anomalies:
○ Quantitative
■ Absolute increase or decrease in
specific white blood cells in response to
stress or infection.
■ Disorder on the number of circulating cells
○ Qualitative
■ Morphological changes in white blood
cells during infections
■ Changes in the normal morphology of
circulating cells
❖ Normal morphology but abnormal
function
● These abnormalities are typically reversible once the
stressful event subsides.

A

STRESS/REACTIVE DISORDER

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Causes: Genetic mutations leading to abnormal
appearance of white blood cells.
● Types of Changes:
○ Quantitative: Changes in the number of
leukocytes.
○ Functional: Changes in the function of
leukocytes.
○ Morphologic: Structural changes in leukocytes.
● Reversibility: These abnormalities are non-reversible.
● Severity: The severity can range from mild to severe.

A

GENETIC DISORDERS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

types of WBC disorders

a. neutrophil
b. monocytes / macrophages
c. eosinophils
d. basophils
e. lymphocytes
f. leukopenia

  1. Increase during acute bacterial infections
  2. Increase during chronic
    infections.
  3. Decrease in WBC count.
  4. Increase during viral infections to help achieve lifetime immunity
  5. Increase during parasitic infections or larval invasions.
  6. Increase in certain immune responses and
    allergic reactions
A
  1. A
  2. B
  3. F
    4.E
  4. C
  5. D
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Increase in neutrophils above 7.0 × 109
/L in adults and
8.5 × 109
/L in children
● Normal Relative Count: Approximately 50% to 70%

A

NEUTROPHILIA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

By adding the number of segmented and band neutrophils (may include metamyelocytes and
myelocytes).

Used to evaluate neutrophelia

A

ANC Calculation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

If there is neutrophilia, there is always
a shift to the (left/right)

A

left

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

leukemoid reaction
a. parasitic infection
b. treponemal infection

A

a

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

neutropenia

associations of leukemoid reaction

A

infections
medications
other conditions (intoxications, hemorrhage, hemolysis, and splenectomy)
Metabolic disease and inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

neutropenia

what is the indicator of leukemoid reactions

A

toxic vacuoles in neutrophils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

neutropenia

Presence of immature neutrophils nucleated red blood
cells (RBCs), and teardrop RBCs in a peripheral blood
smear.
INDICATORS
● Immature Neutrophils and Nucleated RBCs: Key
features of LER.
● Teardrop RBCs: Suggest extramedullary
hematopoiesis and myelofibrosis, especially primary
myelofibrosis.
● Neutrophilia: Often accompanies LER.
ASSOCIATIONS
● Cancers: Space-occupying metastasis, lymphoma,
leukemia, and primary myelofibrosis.
● Other Conditions: Hemolytic disorders, infections,
hemorrhage, and other conditions.
BONE MARROW INVOLVEMENT
● Space-Occupying Lesions: Metastatic tumors,
fibrosis, lymphoma, leukemia, or a marked increase in
one of the normal marrow cells.

A

LEUKOERYTHROBLASTIC REACTION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

a. neutropenia
b. severe neutropenia
c. agranulocytosis

Decrease in the Absolute Neutrophil Count (ANC) to
less than 1.5 × 109
/L

Neutrophil count less than 0.1 ×
109
/L.

ANC less than 0.5 × 109
/L,
significantly increasing the risk of opportunistic
infections.

A

ACB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

CAUSES OF NEUTROPENIA

  • (increased / decreased) rate of removal / destruction
  • (increased/decreased) production / ineffective hematopoiesis
  • circulating vs marginal pool ratio
  • Combination of above factors
A

increased
decreased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

neutropenia

Caused by antibody binding to neutrophil antigens

A

IMMUNE-MEDIATED NEUTROPENIA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

neutropenia

Cause: Maternal IgG crosses the placenta and binds to
neutrophil-specific antigens inherited from the father
(e.g., FcgRIIIb, NB1, HLA).
● Incidence: Approximately 1 in 2000 births.
● Neutrophil Count: Increases or returns to normal after
a few months as maternal antibodies decline and
disappear from the baby’s circulation.

A

ALLOIMMUNE NEONATAL NEUTROPENIA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

neutropenia

Primarily Affects: Children.
● Cause: Development of antibodies to HNA-1.
● Severity: Moderate to severe neutropenia.
● Nature: Self-limiting

A

AUTOIMMUNE NEUTROPENIA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

neutropenia

Associated Conditions: Autoimmune disorders such
as rheumatoid arthritis (RA), Felty syndrome, systemic
lupus erythematosus (SLE), and Sjogren syndrome.
● Other Factors: Immune complex deposition,
granulopoiesis-inhibiting cytokines, and splenomegaly
can also induce neutropenia.

A

SECONDARY AUTOIMMUNE NEUTROPENIA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

neutropenia

● Nature: Most often an acquired condition.
● Causes: Numerous, including drug-induced
neutropenia and neonatal alloimmune neutropenia.

A

ACQUIRED NEUTROPENIA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

neutropenia

Source: Most cases of acquired neutropenia.
● Mechanism: Due to myeloid suppression or
immunologic response.

A

DRUG-INDUCED NEUTROPENIA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

neutropenia

2 types of acquired neutropenia

A

drug induced
neonatal alloimmune neutropenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

neutropenia

Mechanism: Maternal immunoglobulin G (IgG) crosses
the placenta and binds to paternal human neutrophil
antigens (HNA) on fetal leukocytes.
● Effect: Antibody-coated neutrophils are removed from
circulation, resulting in an ANC of less than 0.5 × 109
/L,
often within 1 week of birth
● Common HNAs: HNA-1 and HNA-3 (most often
implicated), HNA-2 (historically common).
● Incidence: 0.9% in the U.S. (2021).
● Infections: Usually not life-threatening.
● Recovery: ANC generally normalizes within 6 months
as maternal IgG is cleared from circulation.

A

NEONATAL ALLOIMMUNE NEUTROPENIA (NAN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

neutropenia

NC below the age-specific reference interval and
presence of IgG autoantibodies against one or more
human neutrophil antigens (HNA).

Incidence: Approximately 1 per 100,000 children under
10 years.
● Onset: Typically manifests around 7 to 9 months.
● Symptoms: Mild infections, usually manageable with
conservative approaches.
● Treatment: Routine antibiotic prophylaxis is not
commonly used.
● Prognosis: Self-limiting, with most patients recovering
spontaneously by 4 to 5 years.

A

AUTOIMMUNE NEUTROPENIA (AIN)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

neutropenia

Common in Adults: Associated with various conditions
and factors.
● Associated Conditions:
○ Connective tissue disorders.
○ Felty syndrome.
○ Hematopoietic neoplasms.
○ Solid tumors.
○ Primary immunodeficiencies.
○ Bacterial and viral infections.
○ Transplant.
○ Idiosyncratic reactions to medications.
● Immunologic Mechanisms:
○ Formation of immune complexes.
○ Haptens.
○ Drug-induced formation of neutrophil
autoantibodies.
○ T-lymphocyte toxicity.

A

AUTOIMMUNE NEUTROPENIA (AIN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

causes cyclic neutropenia

A

ELANE mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
# Neutropenia * Less severe than Severe Congenital Neutropenia (SCN1), which also involves ELANE mutations * Episodes of severe neutropenia (less than 0.2 × 109 /L) occur in approximately 21-day cycles, each lasting 3 to 5 or more days * Accompanied by absolute monocytosis
causes cyclic neutropenia
26
all but one is a symptom of neutropenia episodes Mouth ulcers ● Sore throat ● Gingivitis ● Rash ● lesions ● Fatigue ● Fever ● Cervical lymphadenopathy
lesions
27
Cyclic neutropenia has (high / no / lower) risk of life threatening infections compared to SCN1
lower
28
Adult predominantly affects women 18 to 35 y.o., generally shows more immature neutrophils than mature neutrophil
CHRONIC IDIOPATHIC NEUTROPENIA
29
# EOSINOPHILIA Increase in circulating eosinophils with an absolute count above 0.4 × 109 /L ○ Nonmalignant causes of eosinophilia ○ Cytokine stimulation, especially from interleukin-3 and interleukin-5 (IL3 and IL5)
EOSINOPHILIA
30
# EOSINOPHILIA (>1.5 × 109 /L) lasting more than 6 months without an identifiable cause, the diagnosis is most likely; considered myeloproliferative neoplasm
HYPEREOSINOPHILIC SYNDROME (HES)
31
An absolute count of basophils greater than 0.15 × 109 /L ○ The presence of a malignant myeloproliferative neoplasm such as chronic myelogenous leukemia
BASOPHILIA
32
* Absolute monocyte count greater than 1.0 × 109 /L in adults and greater than 3.5 × 109/L in neonates * First sign of recovery from acute overwhelming infection or severe neutropenia * Most commonly after cancer chemotherapy positive sign of recovery
MONOCYTOSIS
33
Absolute monocyte count of less than 0.2 × 109 /L ○ Very rare in conditions which do not also involve cytopenias of other lineage(s) such as aplastic anemia or chemotherapy-induced cytopenia
MONOCYTOPENIA
34
# monocytopenia matching type a. aplastic anemia b. myelosuppressive therapies c. steroid therapy d. hemodialysis e. sepsis f. viral infections 1. Often with other cytopenias. 2. Especially Epstein-Barr virus (EBV). 3. Associated with monocytopenia 4. Linked to monocytopenia. 5. Common cause. 6. Patients may experience it.
1. A 2. F 3. E 4. C 5. B 6. D
35
# MONOCYTOPENIA association type profound monocytopenia a. Hairy Cell Leukemia b. Myeloid Neoplasms with Germline GATA2 Mutations
both
36
Absolute lymphocytes count greater than 10.0 × 109 /L (young children) ● Absolute lymphocytes count greater than 4.5 × 109 /L (adult)
LYMPHOCYTOSIS
37
# LYMPHOCYTOSIS a. relative b. absolute 1. percentage of lymphocytes is increased but the absolute lymphocyte count is within the normal range 2. exceeds the upper limit of norma
AB
38
Absolute lymphocyte count below 2.0 × 109 /L (young children) ● Absolute lymphocyte count below 1.0 × 109 /L
LYMPHOCYTOPENIA
39
A. newborn infants B. children older than 2 weeks, younger than 8-10 years 1. normally have higher absolute lymphocyte counts than adults 2. have lymphocyte counts very similar to those of adults
BA
40
# Quantitative disorders Sex-linked recessive, autosomal dominant or autosomal recessively inherited disorders with a heterogeneous presentation causing premature cell aging, primarily affecting skin, nails, and bone marrow
DYSKERATOSIS CONGENITA (DC)
41
CAUSES ● Gene mutations impacting telomere maintenance (e.g., DKC1, TERT) FEATURES ● Skin: hyperpigmentation, nail dystrophy, oral leukoplakia ● Bone: marrow failure (cytopenias) and increased cancer risk DIAGNOSIS ● Genetic testing and telomere analysis TREATMENT ● Hematopoietic stem cell transplantation (HSCT) for bone marrow failure ● Supportive care: cancer monitoring and symptom management
DYSKERATOSIS CONGENITA (DC)
42
CLASSIFICATION ● Rare genetic disorder affecting bone marrow, pancreas, and bones CAUSES ● Mutation in the SBDS gene (autosomal recessive) SYMPTOMS ● Blood: Neutropenia, anemia, thrombocytopenia ● Pancreas: Digestive issues, poor growth, malabsorption, steatorrhea ● Bones: Delayed growth, skeletal abnormalities ● Other: Developmental delays, severe infections, failure to thrive DIAGNOSIS ● Genetic testing (DNA sequencing) ● Blood counts ● Pancreatic enzyme tests TREATMENT ● G-CSF: For neutropenia and severe infections ● Enzyme replacement: For digestive issues ● Bone marrow transplant: For severe cases, especially with bone marrow failure, MDS, or AML
SHWACHMAN-DIAMOND SYNDROME (SDS)
43
● Rare inherited disorder (autosomal recessive or Xlinked) causing bone marrow failure, cytopenias, and increased cancer risk ● Cause: FA gene mutations (e.g., FANCA, FANCC) disrupt DNA repair, leading to genetic instability ● Features ○ Hematologic: anemia, leukopenia, thrombocytopenia ○ Physical: short stature, skin pigmentation changes, skeletal anomalies ○ Cancer: increased risk of leukemia, MDS, and other cancers ● Diagnosis: chromosome breakage and genetic test ● Treatment: ○ HSCT for bone marrow failure ○ Androgens and growth factors for blood counts ○ Regular cancer monitoring ● Prognosis: improved with HSCT and surveillance
FANCONI ANEMIA (FA
44
a. fanconi anemia b. fanconi syndrome 1. a kidney disorder impacting electrolyte and nutrient reabsorption in the renal tubules 2. primarily affects the bone marrow and leads to cancerrisk
BA
45
Morphologic abnormalities with and without functional defects ● Normal morphology with functional abnormalities ● Monocyte/macrophage lysosomal storage diseases ● Genetic B and T lymphocyte abnormalities
QUALITATIVE DISORDERS OF LEUKOCYTES
46
● Variants, transformed, or atypical lymphocytes ● Variant lymphocytes indicate stimulation by a virus, particularly EBV, which causes IM
REACTIVE LYMPHOCYTES
47
# NEUTROPHILS – REATIVE MORPHOLOGIC ●Prominent dark purple-black granules in the cytoplasm of neutrophils, unevenly distributed ● Composition: primary granules ● Causes: bacterial infection and sepsis and administration of G-CSF
TOXIC GRANULATION
48
# NEUTROPHILS – REATIVE MORPHOLOGIC ● Appearance: Pale, blue-gray cytoplasmic inclusions. ○ Composition: Aggregates of denatured ribosomal RNA or remnants of rough endoplasmic reticulum. ○ Location: Typically found near the cell membrane. ○ Size and Shape: Vary between 1 and 5 μm in diameter, often indistinct
DOHLE BODIES
49
In ____________, similar inclusions (Dohle bodies) can be found in eosinophils, basophils, and monocytes.
May-Hegglin Anomaly (MHA),
50
# Reactive (Toxic) Morphology in neutrophils **appearance** a. toxic granulation b. Dohle bodies c. Cytoplasmic vacuoles 1. Small to large circular clear areas in cytoplasm; rarely may contain organism 2. Dark, blue-black Cytoplasmic granules 3. Intracytoplasmic, pale blue round or elongated bodies between 1 and 5 μm in diameter, usually adjacent to cellular membranes; can be indistinct
CAB
51
# Reactive (Toxic) Morphology in neutrophils **Associated with** a. toxic granulation b. Dohle bodies c. Cytoplasmic vacuoles 1. inflammation, infection, pregnancy, G-CSF administration 2. Bacterial infection, autophagy secondary to drug ingestion, acute alcoholism, or storage artifact
AB and C
52
Unstained circular area within the cytoplasm ● Causes: bacterial or fungal infection, poisoning, burns, chemotherapy, artifact
VACUOLES
53
# NEUTROPHIL VACUOLATION Occurrence: Less common than toxic granulation (TGs) and Döhle bodies. ● Appearance: Found in neutrophils with toxic granulation and/or Döhle bodies. ● Indication: General sign of phagocytic activity. ● Association: More closely linked to infections than TGs or Döhle bodies alone. ● Characteristics: ○ Variable size (up to 6 μm in diameter). ○ Irregular distribution within the cell. ○ May rarely contain microorganisms. ○ Can coalesce and distort cellular morphology.
TOXIC VACUOLES
54
Process: Cellular degradation involved in neutrophil biology and pathophysiology. ● Formation: Small vacuoles (~2 μm in diameter) with wider cytoplasmic distribution than toxic vacuoles. ● Association: Not linked with toxic granulation or Döhle bodies. ● Occurrence: During cell death, hypoxia, starvation, chemical exposure (including alcohol poisoning), toxic radiation levels, and VEXAS syndrome. ● VEXAS Syndrome: Vacuoles present in other hematopoietic cells.
AUTOPHAGIC VACUOLATION
55
Six or more lobes in granulocyte nucleus ● Causes: megaloblastic anemias, chronic infection, myelodysplastic syndrome, rarely inherited
HYPERSEGMENTATION
56
Degeneration of a cell in which the nucleus shrinks in size and the chromatin condenses to a solid, structureless mass or masses (part of apoptosis, or is indicative of the effects of chemotherapy
PYKNOSIS
57
Indication: Imminent cell death. ● Appearance: ○ Water loss in the nucleus. ○ Dense, dark chromatin. ○ Visible chromatin or filaments between nuclear lobes of segmented neutrophils.
PYKNOTIC NUCLEI
58
Found In: Dead neutrophils. ● Appearance: ○ Rounded, dense nuclear fragments. ○ No visible filaments or chromatin pattern. ○ Presence of granules (key difference from nucleated RBCs, which are agranular). ● Common Confusion: Sometimes mistaken for nucleated RBCs. ● Associated With: Excessive delay between specimen collection and blood film preparation, similar to autophagic vacuoles.
APOPTOTIC NUCLEI
59
Bluish-green or mostly green amorphous, refractile, shiny bodies of irregular shape, size, and number. ● Location: Found in the cytoplasm of neutrophils and occasionally in monocytes. ● Composition: Thought to contain lipofuscin from necrotic liver parenchymal cells. Significance: Often a sign of impending death in critically ill patients.
MONOCYTES
60
Associated With: ○ Infections, including COVID-19 ○ Recovery from myelosuppression ○ Administration of GM-CSF ● Morphological Features: ○ More immature chromatin patterns ○ Small nucleoli ○ Increased nucleus-to-cytoplasm (N:C) ratio ○ Deepened cytoplasmic basophilia ○ Increased vacuoles ○ Distinct granulation
REACTIVE MONOCYTES
61
# T or F Ruptured eosinophils are not counted wih intact eosinophils in microscopic WBC differentials
F (should be counted)
62
Overlooking damaged eosinophils or classifying them as smudge cells can lead to falsely (increased / decreased) eosinophil counts.
decreased
63
Affected basophils may show only a residual pinkish tinge in or around the cell, which might be the only clue that these cells are not neutrophils
HYPOGRANULAR BASOPHILS
64
A rare, inherited autosomal dominant conditions characterized by abnormal nuclear morphology of neutrophils ● Mutations in the lamin b-receptor gene ○ Inner nuclear membrane protein ● Morphology: hyposegmentation, bilobed (“pince-nez” or “dumbbell-shaped”) nuclei ○ Nuclear chromatin is densely clumped
PELGER-HUET ANOMALY (PHA)
65
types of PELGER-HUET ANOMALY (PHA a. heterozygous PHA b. homozygous PHA 1. severe form, very rare. Nearly all neutrophils have a round or oval nucleus (100%) 2. mild form, most common. Neutrophils have bilobed nucleus (55 to 93%)
BA
66
● Hematologic malignancies such as myelodysplastic syndrome (MDS) ● Acute myeloid infection ● Chronic myeloproliferative neoplasms
NEUTROPHILS WITH PHA MORPHOLOGY
67
# PSEUDO PELGER HUET ANOMALY ● HIV infection ● Tuberculosis ● Mycoplasma pneumoniae ● Severe bacteria infection
PSEUDO-PHA NEUTROPHILS
68
DRUGS KNOWN TO INDUCE PSEUDO-PHA INCLUDE EXCEPT: ● Mycophenolate mofetil ● Valproate ● Sulfisoxazole ● Ganciclovir ● Ibuprofen ● Azithromycin ● Chemotherapies such as paclitaxel and docetaxel
azithromycin
69
# Laboratory Issue in Pleger-Huet Anomaly **(True/Congenital and Pseudo/Acquired)** * number of cells affected : 63-93% * WBC lineages : All lineages potentially affected – nuclear shape and chromatin structure * PBS: Neutrophils exhibit normal granulation
TRUE PHA
70
# Laboratory Issue in Pleger-Huet Anomaly **(True/Congenital and Pseudo/Acquired)** * number of cells affected :<38% * WBC lineages : Seen only in neutrophils except – cases of N-MDS-M, E, B-exhibit PHA morphology * PBS: Hypogranular N – common findings – MDS related pseudo PHA
TRUE PHA
71
Nature: Rare, autosomal dominant disorder. ● Affected Cells: Neutrophils, eosinophils, basophils, and monocytes. ● Morphology: ○ Variable thrombocytopenia. ○ Giant platelets. ○ Large Döhle body-like inclusions.
MAY-HEGGLIN ANOMALY
72
Mutations in the MYH9 gene on chromosome 22q12-13
MAY-HEGGLIN ANOMALY
73
* Classification: Rare, fatal hereditary autosomal recessive disorder categorized as familial hemophagocytic lymphohistiocytosis syndrome with hypopigmentation. * Giant, dysfunctional lysosomal granules in neutrophils, monocytes, lymphocytes (Peroxidase-positive deposits)
CHEDIAK-HIGASHI SYNDROME
74
Mutation in the LYST gene on chromosome 1q42.3
CHEDIAK-HIGASHI SYNDROME
75
CHEDIAK-HIGASHI SYNDROME has a high risk of developing which disease * its is characterized to b a life-threatening syndrome of excessive immune action * without treatment most children with CHS succumb to the disease before 7 years
hemophagocytic lymphohistiocytosis
76
all are clinical manifestations of Chediak-higashi disease except one * partial albinism * present in adolescence * severe recurrent life-threatening bacterial infections * mild bleeding * easy bruising * progressive neurologic development
present in **infancy** not adolesence
77
# laboratory findings Chediak-Higashi disease a. PBS b. neutrophil function test 1. delayed bacterial killing 2. shows large, fused granules
BA
78
Resemble CHS granules and are often seen in acute myeloid leukemia (AML), chronic myeloid leukemia, myelodysplastic neoplasms (MDSs), and rarely in acute lymphoblastic leukemia
Pseudo–Chédiak-Higash (PCH)
79
Nature: Rare, autosomal recessive disorder. ● Affected Cells: Granulocytes, monocytes, and lymphocytes. ● Morphology: ○ Large, dark-staining metachromatic cytoplasmic granules (Reilly bodies).
ALDER-REILLY ANOMALY
80
* Large, dark purple-red (metachromatic) granules in neutrophils, eosinophils, and basophils. * Sometimes found in monocytes and lymphocytes. * composed of partially digested mucopolysaccharides.
Alder-Reilly Inclusions / Reilly Bodies